Description
Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.
Cat.No
A013
Name
Ipilimumab
Chemical Properties
CAS
477202-00-9
Synonyms
ipilimumab;70131-50-9;477202-00-9;QZWDCJBBGBXHMW-UHFFFAOYSA-N;8024-01-9;8007-00-9;MDX-010;MDX-010;BMS-734016;BMS-734016
pH value
Corresponds to reference standard： PASS
Non-reduced CE-SDS
98.7%
SEC-HPLC
99.6%
Isoelectric Point
Corresponds to reference standard:PASS
Bacterial Endotoxins Test
＜1 EU/ml
Residual Proteins of Host Cell
Exogenous Residual DNA
＜1 pg/mg
Residual protein A
＜1 ng/mg
Biological Activity
Compared with standard, the range of biological activity is 104%
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard:PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
